France - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, France Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 5% year on year. With 86 Cases in 2019, the country was ranked number 148 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. France is overtaken by Bhutan, which was number 147 with 87 Cases and is followed by France with 85 Cases. India lead the ranking with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 86.00 |
| 2018 | 83.00 |
| 2017 | 79.00 |
| 2016 | 71.00 |
| 2015 | 96.00 |
How does France rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 147 |
#147
Bhutan
|
87 | 2019 | +38.1 % | +8.8 % | View data | |
| 148 |
#148
France
|
86 | 2019 | +3.6 % | -5.0 % | View data | |
| 150 |
#150
Botswana
|
84 | 2019 | -1.2 % | +15.4 % | View data | |